Please provide your email address to receive an email when new articles are posted on . The first Medigus Ultrasonic Surgical Endostapler, or MUSE procedures, for the treatment of gastroesophageal ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related diseases, including gastroesophageal reflux disease (GERD), announced today the ...
Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Patients who undergo Roux-en-Y-gastric bypass have lower odds of developing GERD and esophagitis ...
OMER, ISRAEL--(Marketwired - Mar 14, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
The American Gastroenterological Association (AGA) Center for GI Innovation and Technology today announced a partnership with EndoGastric Solutions® to develop a registry comparing surgery to an ...
OMER, ISRAEL--(Marketwired - Apr 27, 2017) - Medigus Ltd. (NASDAQ: MDGS) (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization ...
Five perendoscopic antireflux devices have received Food and Drug Administration (FDA) approval for clinical use since 2000. Two have been subsequently withdrawn from the market by the manufacturers ...
Broader adoption of MUSE strengthens Medigus' growth potential in Europe following completion of several procedures in leading healthcare institutions Medigus Ltd. (TASE: MDGS), a medical device ...
Professor Pier Alberto Testoni, director of gastroenterology and digestive endoscopy IRCCS at San Raffaele Hospital in Milan, Italy, has performed three MUSE procedures for the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback